Kailera Therapeutics Statistics

NASDAQ: KLRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

10.53-0.30 (-2.77%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 10.53 0.00%

Kailera Therapeutics by the numbers

Kailera Therapeutics has a market capitalization of $1.37 billion based on 129.64M shares outstanding. With trailing EPS of $-4.51, Kailera Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 31.7% below its 50-day average and 44.2% below its 200-day average.

Average daily trading volume is 843.68K shares, or about $8.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

KLRA valuation vs. peer median

KLRA compared with the median of 8 peer companies
Metric	KLRA	Peer median	Difference
Market cap	$1.37B	$1.40B	-2%
Avg. volume	843.68K	714.41K	+18%

Peer median across 8 companies: TYRA, AAPG, NKTR, KRSA, ANAB, GHRS, OMER, RARE.

Valuation

Market cap: $1.37B
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-4.51
Shares outstanding: 129.64M

Price and trading

Previous close: 10.83
Open: 10.77
Day range: 10.50 – 11.12
52-week range: 9.85 – 28.23
50-day moving average: 15.42
200-day moving average: 18.87
Beta: —
Volume: 1.09M
Average volume: 843.68K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 4, 2026

Additional statistics

Market Cap: 1.37B
Forward Pe: -2.45
Eps: -4.51
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 28.23
Week52 Low: 9.85
Avg Volume: 843.68K
Shares Outstanding: 129.64M
Ma50: 15.42
Ma200: 18.87
Earnings Date: Nov 4, 2026
Pct From52w High: -62.70%
Pct From52w Low: 6.90%